Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes.

Tapia G, Mortimer G, Ye J, Gillard BT, Chipper-Keating S, Mårild K, Viken MK, Lie BA, Joner G, Skrivarhaug T, Njølstad PR, Størdal K, Gillespie KM, Stene LC.

Pediatr Diabetes. 2019 Jun 7. doi: 10.1111/pedi.12875. [Epub ahead of print]

PMID:
31173445
2.

Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability.

Rosales C, Gillard BK, Xu B, Gotto AM Jr, Pownall HJ.

Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):47-54. doi: 10.14797/mdcj-15-1-47. Review.

3.

Metabolites Involved in Immune Evasion by Batrachochytrium dendrobatidis Include the Polyamine Spermidine.

Rollins-Smith LA, Ruzzini AC, Fites JS, Reinert LK, Hall EM, Joosse BA, Ravikumar VI, Huebner MI, Aka A, Kehs MH, Gillard BM, Doe E, Tasca JA, Umile TP, Clardy J, Minbiole KPC.

Infect Immun. 2019 Apr 23;87(5). pii: e00035-19. doi: 10.1128/IAI.00035-19. Print 2019 Mar.

PMID:
30833338
4.

Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.

Jarrett KE, Lee C, De Giorgi M, Hurley A, Gillard BK, Doerfler AM, Li A, Pownall HJ, Bao G, Lagor WR.

Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):1997-2006. doi: 10.1161/ATVBAHA.118.311221.

PMID:
30026278
5.

Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.

Gillard BK, Rosales C, Xu B, Gotto AM Jr, Pownall HJ.

J Clin Lipidol. 2018 Jul - Aug;12(4):849-856. doi: 10.1016/j.jacl.2018.04.001. Epub 2018 Apr 12. Review.

PMID:
29731282
6.

The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.

Wyatt RC, Brigatti C, Liberati D, Grace SL, Gillard BT, Long AE, Marzinotto I, Shoemark DK, Chandler KA, Achenbach P, Gillespie KM, Piemonti L, Lampasona V, Williams AJK.

Diabet Med. 2018 Jul;35(7):954-963. doi: 10.1111/dme.13628. Epub 2018 Apr 19.

PMID:
29577424
7.

Regulation of cAMP Responsive Element Binding Protein 3-Like 1 (Creb3l1) Expression by Orphan Nuclear Receptor Nr4a1.

Greenwood MP, Greenwood M, Gillard BT, Chitra Devi R, Murphy D.

Front Mol Neurosci. 2017 Dec 12;10:413. doi: 10.3389/fnmol.2017.00413. eCollection 2017.

8.

A novel LIPS assay for insulin autoantibodies.

Liberati D, Wyatt RC, Brigatti C, Marzinotto I, Ferrari M, Bazzigaluppi E, Bosi E, Gillard BT, Gillespie KM, Gorus F, Weets I, Balti E, Piemonti L, Achenbach P, Williams AJK, Lampasona V.

Acta Diabetol. 2018 Mar;55(3):263-270. doi: 10.1007/s00592-017-1082-y. Epub 2018 Jan 5.

PMID:
29305766
9.

Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model.

Affronti HC, Long MD, Rosario SR, Gillard BM, Karasik E, Boerlin CS, Pellerite AJ, Foster BA, Attwood K, Pili R, Wilton JH, Campbell MJ, Smiraglia DJ.

Oncotarget. 2017 Oct 20;8(61):103758-103774. doi: 10.18632/oncotarget.21911. eCollection 2017 Nov 28.

10.

ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate.

Xu B, Gillard BK, Gotto AM Jr, Rosales C, Pownall HJ.

Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2260-2270. doi: 10.1161/ATVBAHA.117.310290. Epub 2017 Oct 26.

11.

Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.

Mett V, Komarova EA, Greene K, Bespalov I, Brackett C, Gillard B, Gleiberman AS, Toshkov IA, Aygün-Sunar S, Johnson C, Karasik E, Bapardekar-Nair M, Kurnasov OV, Osterman AL, Stanhope-Baker PS, Morrison C, Moser MT, Foster BA, Gudkov AV.

Oncogene. 2018 Jan 25;37(4):439-449. doi: 10.1038/onc.2017.346. Epub 2017 Oct 2.

12.

LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.

Battaglia S, Karasik E, Gillard B, Williams J, Winchester T, Moser MT, Smiraglia DJ, Foster BA.

Clin Epigenetics. 2017 Aug 11;9:82. doi: 10.1186/s13148-017-0382-y. eCollection 2017.

13.

Structural Stability of Streptococcal Serum Opacity Factor.

Yelamanchili D, Gillard BK, Gotto AM Jr, Pownall HJ, Rosales C.

Protein J. 2017 Jun;36(3):196-201. doi: 10.1007/s10930-017-9711-4.

14.

Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester.

Gillard BK, Bassett GR, Gotto AM Jr, Rosales C, Pownall HJ.

J Biol Chem. 2017 May 26;292(21):8864-8873. doi: 10.1074/jbc.M117.781963. Epub 2017 Apr 3.

15.

Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease.

Jarrett KE, Lee CM, Yeh YH, Hsu RH, Gupta R, Zhang M, Rodriguez PJ, Lee CS, Gillard BK, Bissig KD, Pownall HJ, Martin JF, Bao G, Lagor WR.

Sci Rep. 2017 Mar 16;7:44624. doi: 10.1038/srep44624.

16.

Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.

Pownall HJ, Rosales C, Gillard BK, Ferrari M.

Methodist Debakey Cardiovasc J. 2016 Sep;12(3):146-150. Review.

17.

Neo High-Density Lipoprotein Produced by the Streptococcal Serum Opacity Factor Activity against Human High-Density Lipoproteins Is Hepatically Removed via Dual Mechanisms.

Rodriguez PJ, Gillard BK, Barosh R, Gotto AM Jr, Rosales C, Pownall HJ.

Biochemistry. 2016 Oct 18;55(41):5845-5853. doi: 10.1021/acs.biochem.6b00946. Epub 2016 Oct 7.

PMID:
27662183
18.

Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo.

Yang Y, Rosales C, Gillard BK, Gotto AM Jr, Pownall HJ.

Biochim Biophys Acta. 2016 Nov;1861(11):1787-1795. doi: 10.1016/j.bbalip.2016.08.017. Epub 2016 Sep 2.

19.

GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models.

Shourideh M, Azabdaftari G, Attwood K, DePriest A, Wadosky KM, Gillard BM, Karasik E, Heemers H, Kyprianou N, Gelman IH, Corey E, Vessella RL, Mohler JL, Koochekpour S.

Clin Cancer Res. 2016 Jul 25. pii: clincanres.0137.2016. doi: 10.1158/1078-0432.CCR-16-0137. [Epub ahead of print] Retraction in: Clin Cancer Res. 2017 Jul 15;23 (14 ):3973.

PMID:
27458247
20.

Speciated High-Density Lipoprotein Biogenesis and Functionality.

Rosales C, Davidson WS, Gillard BK, Gotto AM Jr, Pownall HJ.

Curr Atheroscler Rep. 2016 May;18(5):25. doi: 10.1007/s11883-016-0572-7. Review.

PMID:
27005803
21.

The essential role of methylthioadenosine phosphorylase in prostate cancer.

Bistulfi G, Affronti HC, Foster BA, Karasik E, Gillard B, Morrison C, Mohler J, Phillips JG, Smiraglia DJ.

Oncotarget. 2016 Mar 22;7(12):14380-93. doi: 10.18632/oncotarget.7486.

22.

Epigenetic Control of the Vasopressin Promoter Explains Physiological Ability to Regulate Vasopressin Transcription in Dehydration and Salt Loading States in the Rat.

Greenwood MP, Greenwood M, Gillard BT, Loh SY, Paton JF, Murphy D.

J Neuroendocrinol. 2016 Apr;28(4). doi: 10.1111/jne.12371.

23.

Direct Measurement of the Structure of Reconstituted High-Density Lipoproteins by Cryo-EM.

Murray SC, Gillard BK, Ludtke SJ, Pownall HJ.

Biophys J. 2016 Feb 23;110(4):810-6. doi: 10.1016/j.bpj.2015.10.028. Epub 2015 Dec 30.

24.

Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo.

Gillard BK, Rodriguez PJ, Fields DW, Raya JL, Lagor WR, Rosales C, Courtney HS, Gotto AM Jr, Pownall HJ.

Biochim Biophys Acta. 2016 Mar;1861(3):196-204. doi: 10.1016/j.bbalip.2015.12.006. Epub 2015 Dec 18.

25.

Metastatic phenotype in CWR22 prostate cancer xenograft following castration.

Seedhouse SJ, Affronti HC, Karasik E, Gillard BM, Azabdaftari G, Smiraglia DJ, Foster BA.

Prostate. 2016 Mar;76(4):359-68. doi: 10.1002/pros.23127. Epub 2015 Dec 8.

26.

High-Density Lipoprotein Processing and Premature Cardiovascular Disease.

Rosales C, Gillard BK, Gotto AM Jr, Pownall HJ.

Methodist Debakey Cardiovasc J. 2015 Jul-Sep;11(3):181-5. doi: 10.14797/mdcj-11-3-181. Review.

27.

Alcohol: a nutrient with multiple salutary effects.

Pownall HJ, Rosales C, Gillard BK, Gotto AM Jr.

Nutrients. 2015 Mar 18;7(3):1992-2000. doi: 10.3390/nu7031992. Review.

28.

Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism.

Rosales C, Patel N, Gillard BK, Yelamanchili D, Yang Y, Courtney HS, Santos RD, Gotto AM Jr, Pownall HJ.

Biochemistry. 2015 Apr 14;54(14):2295-302. doi: 10.1021/bi501486z. Epub 2015 Apr 2.

29.

Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts.

Miles KM, Seshadri M, Ciamporcero E, Adelaiye R, Gillard B, Sotomayor P, Attwood K, Shen L, Conroy D, Kuhnert F, Lalani AS, Thurston G, Pili R.

PLoS One. 2014 Nov 13;9(11):e112371. doi: 10.1371/journal.pone.0112371. eCollection 2014.

30.

Setting the course for apoAII: a port in sight?

Pownall HJ, Gillard BK, Gotto AM Jr.

Clin Lipidol. 2013 Oct;8(5):551-560.

31.

A genome-wide RNAi screen identifies FOXO4 as a metastasis-suppressor through counteracting PI3K/AKT signal pathway in prostate cancer.

Su B, Gao L, Baranowski C, Gillard B, Wang J, Ransom R, Ko HK, Gelman IH.

PLoS One. 2014 Jul 1;9(7):e101411. doi: 10.1371/journal.pone.0101411. eCollection 2014.

32.

Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer.

Ajibade AA, Kirk JS, Karasik E, Gillard B, Moser MT, Johnson CS, Trump DL, Foster BA.

PLoS One. 2014 Feb 26;9(2):e89555. doi: 10.1371/journal.pone.0089555. eCollection 2014.

33.

Src controls castration recurrence of CWR22 prostate cancer xenografts.

Su B, Gillard B, Gao L, Eng KH, Gelman IH.

Cancer Med. 2013 Dec;2(6):784-92. doi: 10.1002/cam4.144. Epub 2013 Oct 11.

34.

Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.

Vasudevan M, Tchoua U, Gillard BK, Jones PH, Ballantyne CM, Pownall HJ.

J Clin Lipidol. 2013 Nov-Dec;7(6):661-70. doi: 10.1016/j.jacl.2013.05.004. Epub 2013 May 25.

35.

Free cholesterol determines reassembled high-density lipoprotein phospholipid phase structure and stability.

Auton M, Bassett GR, Gillard BK, Pownall HJ.

Biochemistry. 2013 Jun 25;52(25):4324-30. doi: 10.1021/bi4006732. Epub 2013 Jun 14.

36.

Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function.

Gillard BK, Raya JL, Ruiz-Esponda R, Iyer D, Coraza I, Balasubramanyam A, Pownall HJ.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1714-21. doi: 10.1161/ATVBAHA.113.301538. Epub 2013 May 2.

37.

Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients.

Vu CN, Ruiz-Esponda R, Yang E, Chang E, Gillard B, Pownall HJ, Hoogeveen RC, Coraza I, Balasubramanyam A.

Metabolism. 2013 Jul;62(7):1014-20. doi: 10.1016/j.metabol.2013.01.020. Epub 2013 Mar 19.

38.

Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients.

Wooten JS, Nambi P, Gillard BK, Pownall HJ, Coraza I, Scott LW, Nambi V, Ballantyne CM, Balasubramanyam A.

Med Sci Sports Exerc. 2013 Jun;45(6):1043-50. doi: 10.1249/MSS.0b013e3182843961.

39.

Definition of molecular determinants of prostate cancer cell bone extravasation.

Barthel SR, Hays DL, Yazawa EM, Opperman M, Walley KC, Nimrichter L, Burdick MM, Gillard BM, Moser MT, Pantel K, Foster BA, Pienta KJ, Dimitroff CJ.

Cancer Res. 2013 Jan 15;73(2):942-52. doi: 10.1158/0008-5472.CAN-12-3264. Epub 2012 Nov 13.

40.

Cholesterol determines and limits rHDL formation from human plasma apolipoprotein A-II and phospholipid membranes.

Bassett GR, Gillard BK, Pownall HJ.

Biochemistry. 2012 Oct 30;51(43):8627-35. doi: 10.1021/bi3011994. Epub 2012 Oct 16.

41.

Dietary folate deficiency blocks prostate cancer progression in the TRAMP model.

Bistulfi G, Foster BA, Karasik E, Gillard B, Miecznikowski J, Dhiman VK, Smiraglia DJ.

Cancer Prev Res (Phila). 2011 Nov;4(11):1825-34. doi: 10.1158/1940-6207.CAPR-11-0140. Epub 2011 Aug 11.

42.

Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.

Rosales C, Tang D, Gillard BK, Courtney HS, Pownall HJ.

Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1834-41. doi: 10.1161/ATVBAHA.111.224360. Epub 2011 May 19.

43.

Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.

Tchoua U, Rosales C, Tang D, Gillard BK, Vaughan A, Lin HY, Courtney HS, Pownall HJ.

Lipids. 2010 Dec;45(12):1117-26. doi: 10.1007/s11745-010-3484-2. Epub 2010 Oct 24.

44.

Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol.

Gillard BK, Rosales C, Pillai BK, Lin HY, Courtney HS, Pownall HJ.

Biochemistry. 2010 Nov 16;49(45):9866-73. doi: 10.1021/bi101412m. Epub 2010 Oct 25.

45.

Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate.

Morey Kinney SR, Zhang W, Pascual M, Greally JM, Gillard BM, Karasik E, Foster BA, Karpf AR.

Cancer Prev Res (Phila). 2009 Dec;2(12):1065-75. doi: 10.1158/1940-6207.CAPR-09-0010. Epub 2009 Nov 24.

46.

HDL superphospholipidation enhances key steps in reverse cholesterol transport.

Tchoua U, Gillard BK, Pownall HJ.

Atherosclerosis. 2010 Apr;209(2):430-5. doi: 10.1016/j.atherosclerosis.2009.10.002. Epub 2009 Oct 12.

47.

Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

Gillard BK, Lin HY, Massey JB, Pownall HJ.

Biochim Biophys Acta. 2009 Dec;1791(12):1125-32. doi: 10.1016/j.bbalip.2009.07.004. Epub 2009 Jul 25.

48.

Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.

Rosales C, Gillard BK, Courtney HS, Blanco-Vaca F, Pownall HJ.

Biochemistry. 2009 Aug 25;48(33):8070-6. doi: 10.1021/bi901087z.

49.

Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I.

Han M, Gillard BK, Courtney HS, Ward K, Rosales C, Khant H, Ludtke SJ, Pownall HJ.

Biochemistry. 2009 Feb 24;48(7):1481-7. doi: 10.1021/bi802287q.

50.

Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Chung I, Han G, Seshadri M, Gillard BM, Yu WD, Foster BA, Trump DL, Johnson CS.

Cancer Res. 2009 Feb 1;69(3):967-75. doi: 10.1158/0008-5472.CAN-08-2307. Epub 2009 Jan 13.

Supplemental Content

Loading ...
Support Center